WASHINGTON, DC-Children afflicted with a rare genetic disease may be helped with a new artificial skin.
The Food and Drug Administration (FDA) recently approved the skin. Children who have epidermolysis bullosa have severe blisters that can scar and leave the fingers melded together like a mitten. Their fingers must be separated surgically, wrapped in non-sticky bandages and healed with skin grafts. The healing process takes extensive amounts of time, leaving the door open for infection.
New York-based Ortec International Inc., wants to change this process with a composite cultured skin made from living skin cells and the foreskins from circumcised newborn baby boys. The new artificial skin is aimed at those who are severely affected by the disease. There are 4,000 people diagnosed per year with EB.
Australian surgeons using the new skin found it helped speed up the healing process, therefore, preventing infection.
Information from www.washingtonpost.com
Gag Order Puts Public Health at Risk, APIC Urges Immediate Action
February 4th 2025APIC warns that the HHS gag order on CDC communications endangers public health, delaying critical infection updates and weakening outbreak response amid rising tuberculosis, avian flu, Ebola, and measles threats.
Breaking Barriers: The Future of HIV Prevention and the Fight for Widespread PrEP Access
January 31st 2025Despite medical advances, HIV prevention faces roadblocks—low PrEP adoption, stigma, and accessibility issues threaten progress. Experts push for innovative, long-acting solutions to end the epidemic.
The Hidden Dangers of Hospital Ventilation: Are We Spreading Viruses Further?
January 31st 2025New research reveals hospital ventilation and air purifiers may unintentionally spread viral particles, increasing infection risks. Infection preventionists must rethink airflow strategies to protect patients and staff.